Tag

Drug Pricing

All articles tagged with #drug pricing

politics2 days ago•8 min saved

PhRMA's Steve Ubl to step down by year-end, triggering CEO search

Steve Ubl, CEO of the Pharmaceutical Research and Manufacturers of America, will depart at the end of the year after a decade leading the branded-drug lobby, leaving a leadership gap as Congress pressures lower drug costs and the administration pursues pricing reforms. The board will search for a successor, with Ubl remaining through a smooth transition; Lori Reilly is considered a leading internal candidate as PhRMA navigates IRA-era price negotiations and rising industry scrutiny.

via Politico|

#drug-pricing #lobbying #lori-reilly

health3 days ago•19 min saved

PhRMA chief resigns amid Trump drug-pricing clash

Steve Ubl, PhRMA’s CEO, will step down after steering the drug industry toward a tougher lobbying stance as Washington and President Trump spar over drug prices, including threats of tariffs; a successor will be named as the pricing fight continues.

via The Washington Post|

#donald-trump #drug-pricing #health

health23 days ago•5 min saved

TrumpRx: Small Discounts, Big Questions on Real Price Relief

TrumpRx.gov, launched to curb prescription costs, has offered discounts on only 54 drugs—many with cheaper generics or other savings options—and remains far from an insurance-friendly tool, with limited awareness; experts say its real impact hinges on scale, broader drug coverage, price transparency, and potential congressional action to codify MFN-style deals into law.

via NBC News|

#drug-pricing #health #health-policy

healthcare1 month ago•7 min saved

TrumpRx Promises Grand Savings, Delivers Narrow Drug List After One Month

One month after its launch, TrumpRx has only a small catalog of drugs (44 listed) despite lofty promises of broad discounts, with many items already available as generics and no clear usage data released. Private deals with drugmakers remain in flux, limiting impact on prices, while administration officials trumpet progress amid bipartisan scrutiny and questions about affordability gains for most patients.

via statnews.com|

#drug-pricing #generics #healthcare

health-policy2 months ago•3 min saved

TrumpRx Promises the Cheapest Drugs, Yet Generics Undercut Many Offers

STAT found that TrumpRx markets deep cash discounts for about 43 brand-name drugs, but at least 18 of them have cheaper generics available on GoodRx or Cost Plus Drugs; TrumpRx only displays cash prices and does not sell medicines directly, highlighting that many savings come from generic options rather than the site’s claims.

via statnews.com|

#drug-pricing #generics #health-policy

politics2 months ago•5 min saved

TrumpRx Debuts Amid Skepticism Over Pricing Impact

The White House launched TrumpRx (trumprx.gov) to help uninsured Americans find discounted prices for high-cost, brand-name drugs. It doesn’t sell drugs directly; users browse discounted medicines and either receive coupons at pharmacies or are redirected to manufacturers’ sites. Discounts come from voluntary 'most favored nation' deals with 16 major drugmakers, but full terms are not public. Economists say the savings are likely modest and mainly increase price transparency; the platform could help those not covered by insurance, especially for lifestyle drugs like fertility or weight-loss treatments. Democrats criticize it as a vanity project and raise concerns about potential conflicts with BlinkRx and Trump family involvement; long-term impact remains uncertain.

via latimes.com|

#blinkrx #democrats #drug-pricing

healthcare2 months ago•1 min saved

Most TrumpRx-listed drugs have cheaper generics, study finds

TrumpRx’s price list shows many branded meds have cheaper generic alternatives: for example, Pristiq can be found for about $200 for 30 days, while generics cost under $30 and even as low as $16.65 on CostPlusDrugs. Experts warn the site may not benefit cash buyers and could steer patients toward pricier branded options, though the White House says it aims to offer the lowest-cost branded choices. Regulators note generics are generally safe and equivalent, though some critics point to FDA testing gaps highlighted by investigations.

via Axios|

#costplusdrugs #drug-pricing #generics

politics2 months ago•6 min saved

TrumpRx launches discount drug portal, aims to cut costs but skeptics doubt sweeping savings

President Trump unveiled TrumpRx, a direct-to-consumer site offering discounts on about 40 branded medicines from five major drugmakers with GoodRx backing; experts say savings may be muted for many since insurance plans and deductibles often yield lower costs, and pricing details remain unclear. The administration touts it as transformative, but critics warn it could curb competition and that broader Medicare drug-price negotiations would be more effective. A potential Express Scripts agreement could expand coverage if the regulatory environment allows, signaling that Congress may need to act to count purchases toward deductibles.

via Politico|

#direct-to-consumer #drug-pricing #goodrx

politics2 months ago•5 min saved

TrumpRx: White House rolls out cash-pay drug hub to lower costs

The White House announced TrumpRx, a direct-to-consumer hub that directs cash-paying patients to discounts offered by drugmakers on their own sites, as part of efforts to lower U.S. prescription costs. The site does not sell drugs itself and may not benefit insured patients who rely on coverage, but could help uninsured or underinsured access drugs not widely covered, such as obesity medications; participating makers include Lilly and Novo Nordisk, with prices advertised (e.g., Ozempic and Wegovy at about $350/month) amid broader debated savings, since actual prices often depend on rebates and payer contracts. The overall impact on out-of-pocket costs remains uncertain.

via CNBC|

#direct-to-consumer #discounts #drug-pricing

health2 months ago•2 min saved

Medicare to Negotiate Botox and 14 Other High-Cost Drugs This Year

Medicare announced the next round of price negotiations under the Inflation Reduction Act, targeting Botox plus 14 other expensive drugs (including Trulicity) used for cancer, diabetes, Crohn’s disease, ulcerative colitis, and rheumatoid arthritis. The negotiated prices, affecting about $27 billion in Medicare Part B and Part D spending, will take effect in 2028. Drugmakers can opt out, but historically none have; Part B covers clinic-administered drugs and Part D covers prescriptions.

via NBC News|

#botox #cms #drug-pricing

healthcare2 months ago•15 min saved

White House flags 15 drugs for Medicare price negotiations

The White House announced that 15 prescription drugs will be included in Medicare's price-negotiation program, a major move aimed at lowering U.S. prescription costs, disclosed during a rural health care event with the President and key health officials in attendance.

via AP News|

#drug-pricing #health-policy #healthcare

policy2 months ago•3 min saved

House Questions Health-Insurance Chiefs Over Premium Surges and Denials

In back-to-back House hearings, major health-insurance CEOs faced bipartisan grilling over rising premiums, prior-authorization rules, and claim denials, with lawmakers scrutinizing the role of PBMs and drug costs while insurers defend pricing as reflecting broader cost pressures in the system and subsidies remaining a political flashpoint.

via NBC News|

#drug-pricing #health-insurance #healthcare-policy

business2 months ago•7 min saved

Pharma Bets on Deals as Patents Fade and Pricing Shifts Shape 2026

At the JPMorgan Healthcare Conference, pharma executives signaled that 2026 could begin a recovery as pricing deals reduce uncertainty and patent expirations drive more dealmaking; leaders from Merck, Bristol Myers Squibb, Novo Nordisk, AstraZeneca and Pfizer outlined plans to offset price pressure with new products and BD activity, while vaccine policy shifts add political headwinds.

via CNBC|

#business #dealmaking #drug-pricing

politics2 months ago•44 min saved

Trump’s So-Called Great Healthcare Plan Lacks Details and Conviction

President Trump rolled out a so‑called “Great Healthcare Plan” that is more a set of familiar ideas than a real, detailed proposal: 350 words online with an 825‑word fact sheet and little in the way of numbers, specifics, or a clear path through Congress. The plan endorses moving some subsidies into health savings accounts and funding cost-sharing reductions, but the math could actually raise costs or reduce coverage for many Americans, and the CBO warns hundreds of thousands could drop coverage. GOP ambivalence and a lack of coordination with bipartisanship discussions further undermine any sense of a serious bill. Critics say the plan amounts to publicity rather than policy, and the broader challenge remains tackling drug prices and reform through genuine legislative effort, not marketing hype.

via The Bulwark|

#affordable-care-act #drug-pricing #healthcare

politics2 months ago•13 min saved

Trump unveils sweeping GOP health-care blueprint focused on price cuts and transparency

Trump unveiled a comprehensive health-care blueprint aimed at enshrining his executive actions into law, pressuring Congress to codify drug-price deals (including most-favored-nation provisions), expand price transparency for insurers and providers, fund cost-sharing reductions, and launch a consumer-focused discount site, while Republicans remain divided over subsidies and abortion provisions and critics warn the plan may struggle to pass.

via Politico|

#drug-pricing #health-care #obamacare